Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
PMID: 20974732
Nevertheless, empagliflozin consistently slowed eGFR decline compared with placebo across all subgroups [48]
Hlaa N, agar T, Katelan M, Brajac I, Prpi-Massari L
Pharmacotherapy (Second-Line) Indicated when BMI 30 (or 27 with comorbidity) and lifestyle modification alone is insufficient
2003, Miami Research Associates
GLP-1 analogs decrease both fasting and postprandial blood glucose levels without causing hypoglycemia and while enabling modest weight loss, a significant achievement for many patients with type 2 diabetes
US$ 28.72
US$ 26.18
US$ 23.00
US$ 20.98
US$ 24.20
US$ 29.84
US$ 26.65
US$ 24.73
US$ 21.07
